Efficacy and Safety of an Oral Somatostatin DNA Vaccine without Antibiotic Resistance Gene in Promoting Growth of Piglets
Efficacy and Safety of an Oral Somatostatin DNA Vaccine without Antibiotic Resistance Gene in Promoting Growth of Piglets
复制标题
口服不含抗生素抗性基因的生长抑素DNA疫苗促进仔猪生长的有效性和安全性
DOI:
10.1111/sji.12155
复制
发表时间:
2014-04-01
影响因子:
3.7
通讯作者:
Yang, L. -G.
中科院分区:
文献类型:
--
作者:
Han, Y. -G.;Liang, A. -X.;Yang, L. -G.
This study aimed to evaluate the efficacy and safety of an oral DNA vaccine against somatostatin (SS) (pGS/2SS-asd, encoding two copies of somatostatin genes) mediated by attenuated Salmonella choleraesuis C500 without antibiotic resistance gene on piglets growth. A total of 50 piglets were uniformly divided into five groups. The animals in the first three groups were orally given vaccine in dose of either 5x10(10), 5x10(9) or 5x10(8) colony-forming units (CFU). The remaining two groups were orally administered with either bacteria C500 (containing pVAX-asd plasmid without somatostatin gene) or phosphate-buffered saline (PBS) as controls. The results indicated that the vaccine induced SS-specific antibodies in a dose-dependent pattern. Compared with the PBS control, animals in the high-dose group showed lower SS levels and higher growth hormone (GH) levels in sera. Average daily gain of animals in the high-dose group was increased by 32.88% and 26.46% during 4 and 8weeks, respectively. Anti-SS antibodies were positively correlated with either GH levels or average daily gain at week 8 after primary immunization (P